(Total Views: 486)
Posted On: 10/28/2021 4:20:51 PM
Post# of 148902
So, I used to wonder, way back at the $5+ level what the guys posting all the negative crap about were trying to accomplish. Thought they were merely shorts. But, as we bumped up and down, I seriously struggled with my 30%, then 40%, even 50% losses (paper only).
I kept reminding myself about what I had learned about mabs in general and Leronlimab specifically. I kept averaging down, sure we would bounce up and I would feel blessed to have bought all those extra shares at such a bargain.
It has become clearer and clearer as time marches on. There are several different groups on the bashing boat. Yes, some are genuinely angry about their paper losses, they often blame NP, sometimes Kelly, sometimes FDA, sometimes BOD, maybe even God. They believe in the science, but are angry.
Another group are the real shorts, just trying to knock the price down to make dollars at first, now only pennies. Many see them as bottom feeders, scum, less than worthless, but I get it. Personally, I have shorted stocks a little, tried it and just did not like it. It felt like I was somehow causing a company to teeter and hoping I could maximize my profit, but bail out before it collapsed on me.
The third group are a combination of raiders and gun slingers. They cannot go in the front door and rob a company, but they can sure as hell set out to rob all of us. They can win, IF the stars align and there are enough weak hands that willingly cede control to them.
Nader has made many errors in judgement, he has not been as forthcoming in owning his errors as he should, but honest recognition for the Herculean efforts he gives us cannot be overstated. What he MUST do IMHO is to elevate Kelly and Recknor. NO, he does NOT need to step down, he simply needs to do everything he possibly can to get the quorum and vote on November 24th and by then, announce that Dr. Kelly will doing xyz, Dr Recknor will head science, trials, regulatory filings. Nader will continue to handle fund raising and investor relations, along with being the more or less ceremonial CEO.
Many, including me, feel like we could do with a lot less promotional videos, these can become direct to target with the assistance of the pr guys, after clearance by the lawyers. These types of moves will set him up for a graceful exit, AFTER our first several approvals, when we are north of $30 on our share price.
I kept reminding myself about what I had learned about mabs in general and Leronlimab specifically. I kept averaging down, sure we would bounce up and I would feel blessed to have bought all those extra shares at such a bargain.
It has become clearer and clearer as time marches on. There are several different groups on the bashing boat. Yes, some are genuinely angry about their paper losses, they often blame NP, sometimes Kelly, sometimes FDA, sometimes BOD, maybe even God. They believe in the science, but are angry.
Another group are the real shorts, just trying to knock the price down to make dollars at first, now only pennies. Many see them as bottom feeders, scum, less than worthless, but I get it. Personally, I have shorted stocks a little, tried it and just did not like it. It felt like I was somehow causing a company to teeter and hoping I could maximize my profit, but bail out before it collapsed on me.
The third group are a combination of raiders and gun slingers. They cannot go in the front door and rob a company, but they can sure as hell set out to rob all of us. They can win, IF the stars align and there are enough weak hands that willingly cede control to them.
Nader has made many errors in judgement, he has not been as forthcoming in owning his errors as he should, but honest recognition for the Herculean efforts he gives us cannot be overstated. What he MUST do IMHO is to elevate Kelly and Recknor. NO, he does NOT need to step down, he simply needs to do everything he possibly can to get the quorum and vote on November 24th and by then, announce that Dr. Kelly will doing xyz, Dr Recknor will head science, trials, regulatory filings. Nader will continue to handle fund raising and investor relations, along with being the more or less ceremonial CEO.
Many, including me, feel like we could do with a lot less promotional videos, these can become direct to target with the assistance of the pr guys, after clearance by the lawyers. These types of moves will set him up for a graceful exit, AFTER our first several approvals, when we are north of $30 on our share price.
(11)
(0)Scroll down for more posts ▼
